dexelvucitabine has been researched along with cytidine triphosphate in 13 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 13 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Emm, T; Gallagher, K; Geleziunas, R; Li, Y; Olah, T; Shi, G; Unger, S; Wu, JT | 1 |
Anderson, KS; Murakami, E; Peterson, CN; Ray, AS; Schinazi, RF; Shi, J | 1 |
Erickson-Viitanen, S; Fish, B; Gallagher, K; Geleziunas, R; King, RW; Klabe, R; Otto, MJ; Schinazi, RF; Shi, G; Unger, S; Wu, JT | 1 |
Bacheler, L; Erickson-Viitanen, S; Gallagher, K; Garber, S; Geleziunas, R; Otto, MJ; Schinazi, RF; Shi, G; Wu, JT; Zhang, H | 1 |
James, JS | 1 |
Almond, MR; Liotta, DC; Mao, S; Painter, GR | 1 |
Otto, MJ | 1 |
Beard, A; Cartee, L; De La Rosa, A; Kravec, I; McBrayer, TR; Murphy, RL; Otto, MJ; Schinazi, RF; Schürmann, D; Stuyver, LJ | 1 |
Sax, PE | 1 |
Nelson, MR; Waters, L | 1 |
Bazmi, HZ; Chu, CK; Hammond, JL; Koontz, DL; Mellors, JW; Parikh, UM; Schinazi, RF; Schlueter-Wirtz, S | 1 |
Feinberg, J | 1 |
3 review(s) available for dexelvucitabine and cytidine triphosphate
Article | Year |
---|---|
Biochemical and mechanistic basis for the activity of nucleoside analogue inhibitors of HIV reverse transcriptase.
Topics: Adenine; Cytidine Triphosphate; Deoxycytidine; Deoxycytidine Monophosphate; Deoxyribonucleotides; Dioxolanes; DNA, Viral; Emtricitabine; HIV Infections; HIV Reverse Transcriptase; Humans; Kinetics; Molecular Structure; Nucleosides; Organophosphonates; Organophosphorus Compounds; Phosphorylation; Protein Binding; Protein Conformation; Purine Nucleosides; Reverse Transcriptase Inhibitors; Substrate Specificity; Tenofovir; Zalcitabine | 2004 |
New nucleoside reverse transcriptase inhibitors for the treatment of HIV infections.
Topics: Animals; Anti-HIV Agents; Clinical Trials as Topic; Cytidine Triphosphate; Deoxycytidine; Dideoxynucleosides; Dioxolanes; Emtricitabine; HIV Infections; Humans; Purine Nucleosides; Reverse Transcriptase Inhibitors; Thionucleosides; Zalcitabine | 2004 |
New drugs.
Topics: Anti-HIV Agents; Benzophenones; Cytidine Triphosphate; Darunavir; Deoxycytidine; Emtricitabine; HIV; HIV Fusion Inhibitors; HIV Reverse Transcriptase; Humans; Imidazoles; Nitriles; Protease Inhibitors; Pyridazines; Pyridines; Pyrimidines; Pyrones; Reverse Transcriptase Inhibitors; Sulfonamides; Sulfur Compounds; Zalcitabine | 2005 |
2 trial(s) available for dexelvucitabine and cytidine triphosphate
Article | Year |
---|---|
Potent antiviral effect of reverset in HIV-1-infected adults following a single oral dose.
Topics: Administration, Oral; Adolescent; Adult; Cohort Studies; Cytidine Triphosphate; Dose-Response Relationship, Drug; Drug Administration Schedule; Genotype; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Middle Aged; Reverse Transcriptase Inhibitors; Sequence Analysis, RNA; Viral Load; Zalcitabine | 2004 |
Meeting notes from the 3rd IAS Conference. New drugs.
Topics: Brazil; CCR5 Receptor Antagonists; Congresses as Topic; Cytidine Triphosphate; Darunavir; HIV Infections; Reverse Transcriptase Inhibitors; Sulfonamides; Zalcitabine | 2005 |
8 other study(ies) available for dexelvucitabine and cytidine triphosphate
Article | Year |
---|---|
Novel direct detection method for quantitative determination of intracellular nucleoside triphosphates using weak anion exchange liquid chromatography/tandem mass spectrometry.
Topics: Chromatography, Liquid; Cytidine Triphosphate; Deoxycytidine; Mass Spectrometry; Monocytes; Reverse Transcriptase Inhibitors; Zalcitabine | 2002 |
Interactions of enantiomers of 2',3'-didehydro-2',3'-dideoxy-fluorocytidine with wild type and M184V mutant HIV-1 reverse transcriptase.
Topics: Base Sequence; Binding Sites; Cytidine Triphosphate; Deoxycytosine Nucleotides; HIV Reverse Transcriptase; Kinetics; Models, Molecular; Molecular Sequence Data; Point Mutation; Reverse Transcriptase Inhibitors; Stereoisomerism; Zalcitabine | 2002 |
Cellular pharmacology of D-d4FC, a nucleoside analogue active against drug-resistant HIV.
Topics: Anti-HIV Agents; Cells, Cultured; Cytidine Triphosphate; Drug Interactions; Drug Resistance, Viral; HIV Protease Inhibitors; HIV Reverse Transcriptase; HIV-1; Humans; Intracellular Membranes; Leukocytes, Mononuclear; Nucleosides; Phosphorylation; Phytohemagglutinins; Reverse Transcriptase Inhibitors; Zalcitabine | 2003 |
HIV-1 resistance profile of the novel nucleoside reverse transcriptase inhibitor beta-D-2',3'-dideoxy-2',3'-didehydro-5-fluorocytidine (Reverset).
Topics: Adenine; Anti-HIV Agents; Cell Line; Cytidine Triphosphate; Didanosine; Drug Resistance, Multiple, Viral; Genotype; HIV Reverse Transcriptase; HIV-1; Humans; Lamivudine; Mutation; Organophosphonates; Organophosphorus Compounds; Reverse Transcriptase Inhibitors; Species Specificity; Tenofovir; Transfection; Zalcitabine; Zidovudine | 2003 |
Antiretroviral pipeline: new-drug reports from retroviruses conference.
Topics: Anti-HIV Agents; CCR5 Receptor Antagonists; Cytidine Triphosphate; Drug Resistance, Viral; HIV; HIV Fusion Inhibitors; Membrane Fusion; Zalcitabine | 2004 |
Meeting notes from ICAAC. D-D4FC (Reverset): further data on treatment-experienced patients.
Topics: Anti-HIV Agents; Cytidine Triphosphate; HIV Infections; Humans; Mutation; Viral Load; Zalcitabine | 2005 |
In vitro selection and analysis of human immunodeficiency virus type 1 resistant to derivatives of beta-2',3'-didehydro-2',3'-dideoxy-5-fluorocytidine.
Topics: Amino Acid Substitution; Anti-HIV Agents; Cell Line; Cytidine Triphosphate; Drug Resistance, Viral; HIV Reverse Transcriptase; HIV-1; Humans; Mutagenesis, Site-Directed; Mutation; Reverse Transcriptase Inhibitors; Stereoisomerism; Structure-Activity Relationship; Zalcitabine | 2005 |
dD4FC development discontinued.
Topics: Cytidine Triphosphate; Drug Industry; HIV Infections; Humans; Hyperlipidemias; Reverse Transcriptase Inhibitors; Zalcitabine | 2006 |